This content is restricted.
Brief
"On December 19, 2024, the Ministry of Health and Welfare (MOHW) held the 12th Advanced Regenerative Medicine and Advanced Biopharmaceutical Deliberation Committee. The committee deliberated on nine clinical research plans, including two high-risk, six medium-risk, and one low-risk studies. Two plans were approved, while seven were rejected."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
